跳至主要内容
临床试验/DRKS00016894
DRKS00016894已完成不适用

ong term observational study on efficiency of a TNF-alpha blocker therapy on nail psoriasis in patients with moderate to severe plaque psoriasis or psoriatic arthritis - NAPSI

Abbott GmbH & Co. KG0 个研究点目标入组 755 人开始时间: 2019年6月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
755

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • moderate to severe psoriasis (with PASI, BSA or DLQI > 10)

排除标准

  • Any other skin diseases that could interfere with the evaluation of psoriasis severity or other forms of psoriasis than plaque-type, onychomycosis, latent or active tuberculosis, hepatitis B and C, HIV infection as well as inability to understand the questionnaires and adhere to the trial procedures

研究者

相似试验

ong term observational study on efficiency of a... | 临床试验